https://www.selleckchem.com/products/sr-717.html
There was no CSPC in the groups with PHI 27.0, and Gleason score 7 began to appear in groups with PHI ≥27.0. In particular, patients with Gleason score 8 and 9 were distributed only in the groups with PHI ≥36.0. The diagnostic accuracy of detection of CSPC could be increased when prostate biopsy is performed in patients with a PHI ≥36.0. In this study, there was a clear Gleason score difference when the PHI cutoff value was set to 27.0 or 36.0. The diagnostic accuracy of detection of CSPC could be increased when prostate biopsy is pe